Medicine for treating myocarditis

A technology of myocarditis and drugs, applied in the field of drugs for the treatment of myocarditis, can solve the problems of no good treatment methods, poor efficacy of arrhythmia, and affecting the treatment of myocarditis, and achieve significant curative effect

Inactive Publication Date: 2013-05-29
CHENGDU JIANJIANG PHARMA FACTORY
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the therapeutic effect of Western medicine on myocarditis is not satisfactory.
For patients with viral myocarditis, there are few effective antiviral drugs in Western medicine, which affects the treatment of myocarditis
Also less effective against arrhythmias in patients with chronic myocarditis
Especially the cardiomyopathy developed from myocarditis, the etiology is still unknown, and there is no good treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] The present embodiment is the method for preparing pills.

[0017] Take 2 parts of ginseng, 4 parts of yuanshen, 6 parts of salvia miltiorrhiza, 10 parts of astragalus, 3 parts of honeysuckle, 4 parts of Sanqi, 4 parts of leeches, 2 parts of Chuanxiong, 12 parts of Radix Isatidis, 10 parts of Daqingye, 6 parts of polygala, jujube 8 parts of kernel, 8 parts of angelica, 10 parts of schisandra, 8 parts of licorice, and 1 part of cinnabar. Steam on boiling water at 100°C for 60 minutes, spread out to cool and dry in the sun, crush the above raw materials into fine powder and mix evenly, add cinnamon aldehyde, creatinine, vitamin C, vitamin E, adenosine triphosphate, coenzyme A, potassium chloride, Insulin, glucose and coenzyme Q10, etc., are mixed with honey and water by weight honey: water = 9: 1, and cinnabar is used as a coating to make a pill.

Embodiment 2

[0019] This embodiment is a method for preparing an aqueous solution.

[0020] Take 6 parts of ginseng, 8 parts of yuanshen, 10 parts of salvia miltiorrhiza, 12 parts of astragalus, 3 parts of honeysuckle, 2 parts of notoginseng, 8 parts of leeches, 4 parts of Chuanxiong, 15 parts of Radix Isatidis, 12 parts of Daqingye, 5 parts of polygala, jujube 12 parts of kernels, 12 parts of angelica, 13 parts of schisandra, 12 parts of licorice, and 2 parts of cinnabar.

[0021] Add water that is 6 times the weight of the medicinal materials used and boil, then change to slow fire and boil for 20 minutes after boiling on high heat, filter out, and repeat three times. Mix the three water preparations, add cinnamon aldehyde, creatinine, vitamin C, vitamin E, adenosine triphosphate, coenzyme A, potassium chloride, insulin, glucose, coenzyme Q10 and honey, divide into several parts, and take according to the dosage of ordinary Chinese medicine .

Embodiment 3

[0023] This embodiment is a method for preparing tablets.

[0024] Take 4 parts of ginseng, 6 parts of yuanshen, 8 parts of salvia miltiorrhiza, 8 parts of astragalus, 2 parts of honeysuckle, 3 parts of Sanqi, 6 parts of leeches, 3 parts of Chuanxiong, 10 parts of Radix Isatidis, 8 parts of Daqingye, 3 parts of polygala, jujube 10 parts of kernels, 10 parts of angelica, 5 parts of schisandra, 3 parts of licorice, and 1 part of cinnabar. Steam in boiling water at 100°C for 60 minutes, spread out to cool and then dry in the sun. Grind the above raw materials into fine powder and mix evenly. Add cinnamon aldehyde, creatinine, vitamin C, vitamin E, adenosine triphosphate, coenzyme A, potassium chloride, Insulin, Glucose, and CoQ10. Mix evenly and press into tablets.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating myocarditis. The medicine is prepared from the following materials in parts by weight: 2-6 parts of ginseng, 4-8 parts of radix scrophulariae, 6-10 parts of salvia miltiorrhiza, 8-12 parts of astragalus mongholicus, 2-3 parts of honeysuckles, 2-4 parts of pseudo-ginseng, 4-8 parts of leech, 2-4 parts of Szechuan Lovage Rhizome, 10-15 parts of radix isatidis, 8-12 parts of folium isatidis, 3-6 parts of polygala, 8-12 parts of wild jujube seeds, 8-12 parts of angelica, 5-13 parts of schisandra chinensis, 3-12 parts of liquorice and 1-2 parts of vermilion cinnabar. The medicine further comprises cinnamyl aldehyde, creatinine, vitamin C, vitamin E, adenosine-triphosphate, coenzyme A, potassium chloride, insulin, glucose, coenzyme Q10, and the like. The medicine has the effects of preventing virus, diminishing inflammation, clearing away heat, tonifying heart and replenishing the blood, soothing the nerves and tonifying qi. By combining traditional Chinese and western medicine, the medicine has remarkable curative effect on treating delirium, deficiency of heart-blood, myocarditis, heart strain, angina, worry beyond measure and amnesia.

Description

Technical field [0001] The invention involves a drug that treats heart disease, especially a drug for myocarditis. Background technique [0002] Myocarditis refers to the limited or permeable acute, subacute or chronic inflammatory lesions in myocardium. Generally, myocarditis is a viral myocarditis caused by viral infections.In recent years, the relative incidence of viral myocarditis has continued to increase, the condition is different, the manifestations are very different, the infants and young children are more severe, the adults are mild, and those who are mild may have no obvious symptoms.Disclosure or even sudden death. [0003] At present, Western Medicine's treatment of myocarditis is not ideal.For patients with viral myocarditis, the rare antiviral drugs in western medicine have affected the treatment of myocarditis.The effect of arrhythmia in patients with chronic myocarditis is also poor.In particular, the myocardial disease developed into myocarditis has no good tr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/855A61K36/725A61P9/00A61P9/10A61P31/12A61K31/11A61K31/122A61K31/355A61K31/375A61K31/4168A61K31/7076A61K33/14A61K31/7004A61K33/28A61K35/62A61K38/28
Inventor 张强
Owner CHENGDU JIANJIANG PHARMA FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap